EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation

Title
EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation
Authors
Keywords
-
Journal
MOLECULAR CANCER RESEARCH
Volume 15, Issue 4, Pages 405-417
Publisher
American Association for Cancer Research (AACR)
Online
2017-01-25
DOI
10.1158/1541-7786.mcr-16-0242-t

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started